NOS2 and ovarian cancer: We propose that our suggested mechanism involves NOS inhibition leading to EMT reversal by inhibiting JNK S-nitrosylation and that heightened sensitivity of tumors to PI3K inhibitors and taxane therapy could potentially extend to cancers such as ovarian cancer.